Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Symcel receives grant to advance calScreener efforts
September 2016
SHARING OPTIONS:

STOCKHOLM, Sweden—SymCel was recently awarded a Phase I Horizon 2020 grant to fund a full feasibility study of calScreener, its calorimetry-based diagnostic tool, as the company prepares for commercialization. The study forms Phase I of the Bacterial Analysis and Diagnostics through Growth and Energy in Real-time project, and consists of a comprehensive strategic review of the company, business model visioning and the development of an effective business plan.
 
“Key industry benefits of CalScreener include the fact that it is a high sensitivity, easy-to-use calorimeter that ensures the fast delivery of reliable information on the type of bacteria involved in infections, enabling a quick choice of individualized patient therapy for hard-to-diagnose infections,” said Magnus Jannsson, chief scientific officer at Symcel. “Consequently, once fully commercialized, we believe that our technology is set to have a transformational impact within the healthcare sector.”

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.